Monograph: Grape Seed Extract

Help on accessing alternative formats, such as Portable document format (PDF), Microsoft word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLA) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredient. It is a referenced document to be used as a labelling standard. Note: Text in parentheses is additional optional information which can be included on the PLA and product labels at the applicants' discretion. The solidus (/) indicates that the terms are synonyms or that the statements are synonymous. Either term or statement may be selected by the applicant.
Date: 2018-08-28

NHPID name

Grape seed extract ( Germplasm Resources Information Network Taxonomy )

Proper name(s)

Common name(s)

Grape Seed Extract

Source material

Route Of administration

Oral

Dosage form(s)

Use(s) or purpose(s)

Statement(s) to the effect of:

Dose(s)

Duration of use

Relief of symptoms related to non-complicated CVI: Use for at least 1 month to see beneficial.  (Thébaut et al. 1985, Delacroix 1981, Sarrat 1981) Consult a health care practitioner/health care provider/health care professional/doctor/physician for use beyond 3 months.  (Sano et al. 2007)

Risk information

Statement(s) to the effect of:

Caution(s) and Warning(s): Relief of symptoms related to non-complicated CVI: Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms worsen. Contraindication(s): Consult a healthcare practitioner/health care provider/health care professional/doctor/ physician prior to use if you are pregnant or breastfeeding. Known Adverse Reaction(s): No statement is required

Non-medicinal ingredients

Must be chosen from the current Natural health products ingredients database and must meet the limitations outlined in the database.

Specifications

References cited

References reviewed

Appendix 1: Examples of dosage preparations and frequencies of use

Antioxidant:

Relief of symptoms related to non-complicated CVI: